Impact Biomedical sets 1-for-12.62 reverse split ahead of merger
Tweet Send to a Friend
Impact Biomedical Inc. (NYSE American: IBO) has corrected a previously issued press release to fix an error in the merger ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


